NYSE:MIR - New York Stock Exchange, Inc. - US60471A1016 - Common Stock - Currency: USD
Zacks highlights MIR and RYCEY as under-$20 nuclear stocks poised to ride AI???s massive energy demand wave.
Surging data center power demand and fresh U.S. nuclear policies put CEG, VST, MIR, BWXT, and CCJ in sharp investor focus.
The two highly-ranked stocks trading for $20 a share or less that we dive into today provide investors exposure to long-term, AI-boosted nuclear energy industry expansion.
If you are looking for stocks that are well positioned to maintain their recent uptrend, Mirion Technologies (MIR) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Here is how Mirion Technologies, Inc. (MIR) and Mitie Group PLC. (MITFY) have performed compared to their sector so far this year.
Mirion Technologies (MIR) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Mirion Technologies (MIR) delivered earnings and revenue surprises of 0% and 0.39%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: PSN
We recently published a list of 10 Best Low Cost Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Mirion Technologies, Inc. (NYSE:MIR) stands against other best low cost stocks to buy according to billionaires. Markets are wobbling, and panic is becoming the headline. At times […]
We recently published a list of 10 Pro-Life Companies to Invest In Now. In this article, we are going to take a look at where Mirion Technologies, Inc. (NYSE:MIR) stands against other top pro-life companies to invest in now. Investing isn’t just about numbers—it’s also about values. As socially responsible investing (SRI) gains traction, a […]
Radiation technology company Mirion (NYSE:MIR) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 10.4% year on year to $254.3 million. Its non-GAAP profit of $0.17 per share was 15.1% above analysts’ consensus estimates.